Please login to the form below

Not currently logged in
Email:
Password:

Apogee files two US patent applications for intradermal delivery system

Apogee Technology has filed two US provisional patent applications relating to its intradermal drug delivery technology 

US-headquartered biotech Apogee Technology has filed two US provisional patent applications relating to its intradermal drug delivery technology.  

The new patent applications describe advanced macromolecular formulations and coating methodologies.

Dr Alexander K Andrianov, Apogee's vice-president of R&D, said, "These filings are an important achievement of the company's ongoing research and development programme and are intended to protect rights for formulations with improved coating efficiency, methods and systems for precise dose control."

23rd July 2007

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
BOLDSCIENCE

We know what it takes to create brands, to start new conversations, to simply communicate complex science, to change lives…...

Latest intelligence

Numbers, navigation, and narratives: digital storytelling in medical communications
Science and storytelling aren’t often seen as compatible. One is based on cold, hard facts, while the other is synonymous with improvisation and theater. However, when done well, storytelling can...
Is this common data mistake killing your digital patient recruitment?
Without realising, you could be falling into the trap of using social data — insights into recent, relevant trends and topics — to inspire your content. Hold up. That sounds...
Stick or Twist? Healthcare brands in a (post) COVID-19 world
...